IP Library Granted Patent US 8,067,055
Granted Patent B2
US 8,067,055 · App. 11/690,768 · Granted Nov 29, 2011

Drug-delivery endovascular stent and method of use

Assignee: Biosensors International Group, Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,067,055
App. No.
11/690,768
Granted
Nov 29, 2011
Kind
B2
Abstract

A radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, a method of using, and a method of making the stent. The stent includes a radially expandable body formed of one or more metallic filaments where at least one surface of the filaments has a roughened or abraded surface. The stent may include a therapeutic agent on the abraded surface.

Claims (8)

1. A method of producing a radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, comprising positioning the stent onto a mandrel covered with an exterior mask of hydrocarbon film; crimping the stent into the mask; ensuring that at least a portion of the stent that is not to be abraded is covered by the mask; texturing at least a portion of the stent; and applying a therapeutic agent to at least a portion of the abraded, roughened, or textured portion of the stent.

2. The method according to claim 1 , wherein said applying a therapeutic agent comprises infusing the agent into a substratum formed in the abraded, roughened, or textured surface.

3. The method according to claim 1 , further comprising removing said mask after said texturing.

4. The method according to claim 1 , wherein said texturing comprises microblasting at least a portion of the stent.

5. The method according to claim 1 , wherein said texturing comprises shot peening at least a portion of the stent.

6. The method according to claim 1 , wherein said texturing comprises differentially compressing the stent.

7. The method according to claim 1 , further comprising passivating at least a portion of the stent after said texturing.

8. The method according to claim 1 , wherein said therapeutic agent comprises an anti-restenosis drug.

Assignments (2)
CORRECTION OF NAME AND ADDRESS Recorded Feb 26, 2010
From: BIOSENSORS INTERNATIONAL GROUP
To: BIOSENSORS INTERNATIONAL GROUP, LTD.
Reel/Frame 024001/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2007
From: SAVAGE, DOUGLAS R.; SHULZE, JOHN E.; BETTS, RONALD E.; FARIABI, SEPEHR; SU, SHIH-HORNG
To: BIOSENSORS INTERNATIONAL GROUP
Reel/Frame 019451/0825 →
Continuity (2)
Provisional Application 60853077 · Oct 20, 2006
Related Publication 20080097568A1 · Apr 24, 2008